Clinical predictors for nondiabetic kidney diseases in patients with type 2 diabetes mellitus: a retrospective study from 2017 to 2021
Zeng Y, Yang Y, Guan CJ, et al.
BMC Endocr Disord. 2022;22(1):168
Leggi
Breaking news
Essential CGM metrics: the principal dimensions of glycemic control in diabetes
Montaser E, Fabris C, Kovatchev BP
Diabetes Technol Ther. Pub. online 17 Jun 2022
Leggi
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled
Ferreira JP, Zannad F, Butler J, et al.
Eur Heart J. 2022;ehac306.
Leggi
Evaluation of clinical metrics for identifying defective physiologic responses to hypoglycemia in long-standing type 1 diabetes
Flatt AJ, Chen E, Peleckis AJ, et al.
Diabetes Technol Ther. Pub. online 27 Jun 2022.
Leggi
A systematic review supporting the Endocrine Society clinical practice guideline for the management of hyperglycemia in adults hospitalized for noncritical illness or undergoing elective surgical procedures
O Seisa M, Saadi S, Nayfeh T, et al.
J Clin Endocrinol Metab. 2022;dgac277
Leggi
Obesity in late adolescence and incident type 1 diabetes in young adulthood
Zucker I, Zloof Y, Bardugo A, et al.
Diabetologia. Pub. online 5 Jun 2022.
Leggi
Diabetes and progression of heart failure: the Atherosclerosis Risk In Communities (ARIC) study
Echouffo-Tcheugui JB, Ndumele CE, Zhang S, et al.
J Am Coll Cardiol. 2022;79(23):2285–93.
Leggi
Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes
DeFronzo RA, Bakris G
Diabetes Obes Metab. 2022;24(7):1197-1205.
Leggi
Real-world evidence of improved glycemic control in people with diabetes using a Bluetooth-connected blood glucose meter with a mobile diabetes management app
Grady M, Cameron H, Bhatiker A, et al.
Diabetes Technol Ther. Pub. online 2 Jun 2022.
Leggi